Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
The DOI matches its Crossref record.
Abstract
The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The management of patients with HCC has improved markedly since the first BCLC classification was proposed in 1999143.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [143]
Citations
Cites
Still being checked.
Cited by
Items 801–900 of 1,005
Kabir, T., Syn, N. L. X., Tan, Z. Z. X., Tan, H. J., Yen, C., Koh, Y. X., Kam, J. H., Teo, J., Lee, S. Y., Cheow, P. C., et al. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.03.219 · Cited by 51
Fründt, T., Krause, L., Hussey, E., Steinbach, B., Köhler, D., von Felden, J., Schulze, K., Lohse, A. W., Wege, H., & Schwarzenbach, H. (2021) · Cancers · doi:10.3390/cancers13102484 · Cited by 51
Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
Rich, N. E., & Singal, A. G. (2022) · Hepatology · doi:10.1002/hep.32284 · Cited by 51
Wang, J., Chen, Y., Kee, K., Wang, C., Tsai, M., Kuo, Y., Hung, C., Li, W.-F., Li, W., & Chen, Y. (2022) · Cancers · doi:10.3390/cancers14020343 · Cited by 51
Burak, K. W., & Kneteman, N. M. (2010) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2010/410574 · Cited by 51
Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy
Nakeeb, A. E., Sultan, A. M., Salah, T., Hemaly, M. E., Hamdy, E., Salem, A., Moneer, A., Said, R., AbuEleneen, A., Zeid, M. A., et al. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i41.7129 · Cited by 51
Impact of hepatectomy for huge solitary hepatocellular carcinoma
Ariizumi, S., Kotera, Y., Takahashi, Y., Katagiri, S., & Yamamoto, M. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23226 · Cited by 50
Choi, S. B., Kim, H. J., Song, T.-J., Ahn, H. S., & Choi, S. Y. (2014) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.124 · Cited by 50
Stremitzer, S., Tamandl, D., Kaczirek, K., Maresch, J., Abbasov, B., Payer, B. A., Ferlitsch, A., & Gruenberger, T. (2011) · British journal of surgery · doi:10.1002/bjs.7672 · Cited by 50
Velosa, J., Serejo, F., Marinho, R. T., Nunes, J., & Gloria, H. C. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1621-2 · Cited by 50
Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy
Liu, P., Su, C., Hsu, C., Hsia, C., Lee, Y.-H., Huang, Y., Lee, R., Lin, H., & Huo, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155588 · Cited by 50
Current topics in the surgical treatments for hepatocellular carcinoma
Ban, D., Ogura, T., Akahoshi, K., & Tanabe, M. (2018) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12065 · Cited by 50
Treatment of Combined Hepatocellular and Cholangiocarcinoma
Leoni, S., Sansone, V., Lorenzo, S. D., Ielasi, L., Tovoli, F., Renzulli, M., Golfieri, R., Spinelli, D., & Piscaglia, F. (2020) · Cancers · doi:10.3390/cancers12040794 · Cited by 50
De, B. S., Ng, S. P., Liu, A. Y., Avila, S., Tao, R., Holliday, E. B., Brownlee, Z., Kaseb, A. O., Lee, S., Raghav, K. P. S., et al. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s282062 · Cited by 50
Serenari, M., Cappelli, A., Cucchetti, A., Mosconi, C., Strigari, L., Monari, F., Ravaioli, M., Rizzini, E. L., Fanti, S., Golfieri, R., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26257 · Cited by 50
Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives
Slotta, J. E., Kollmar, O., Ellenrieder, V., Ghadimi, B. M., & Homayounfar, K. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i9.1168 · Cited by 50
Marrero, J. A., & Pelletier, S. J. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.05.012 · Cited by 50
The Prognosis of Liver Cirrhosis in Recent Years in Korea
Kim, Y. S., Um, S. H., Ryu, H. S., Lee, J. B., Lee, J. W., Park, D. K., Kim, Y. S., Jin, Y. T., Chun, H. J., Lee, H. S., et al. (2003) · Journal of Korean Medical Science · doi:10.3346/jkms.2003.18.6.833 · Cited by 49
“For the entire cohort, the mean follow-up duration was 48 (1-94) months.”
BackgroundMethodGuo, Z., Zhong, J., Jiang, J., Zhang, J., Xiang, B., & Li, L. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3704-8 · Cited by 49
Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review
Dionisi, F., Widesott, L., Lorentini, S., & Amichetti, M. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.02.001 · Cited by 49
Gao, X., Qu, J., Chang, X., Lu, Y., Bai, W., Wang, H., Xu, Z., An, L., Wang, C., Zeng, Z., et al. (2013) · Liver International · doi:10.1111/liv.12264 · Cited by 49
Sohn, J. H., Durán, R., Zhao, Y., Fleckenstein, F. N., Chapiro, J., Sahu, S., Schernthaner, R. E., Qian, T., Lee, H., Li, Z., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.036 · Cited by 49
Lo, C., Liu, M., Lee, M., Yang, J.-F., Jen, Y., Lin, C., Chao, H., Shen, P., & Huang, W. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.04.036 · Cited by 49
Wiesinger, I., Wiggermann, P., Zausig, N., Beyer, L. P., Salzberger, B., Stroszczynski, C., & Jung, E. M. (2017) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0043-119353 · Cited by 49
Quagliata, L., Quintavalle, C., Lanzafame, M., Matter, M. S., Novello, C., Tommaso, L. D., Pressiani, T., Rimassa, L., Tornillo, L., Roncalli, M. G., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.107 · Cited by 49
Choi, J. W., Chung, J. W., Lee, D. H., Kim, H., Hur, S., Lee, M., & Jae, H. J. (2017) · European Radiology · doi:10.1007/s00330-017-5145-9 · Cited by 49
Liu, J., Zhang, H., Xia, Y., Yang, T., Gao, Y., Li, J., Wu, Y., & Shen, F. (2018) · HPB · doi:10.1016/j.hpb.2018.07.005 · Cited by 49
Current State of Tumor Ablation Therapies
Bailey, C. W., & Sydnor, M. K. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05514-9 · Cited by 49
Labgaa, I., Taffé, P., Martin, D. J., Clerc, D., Schwartz, M., Kokudo, N., Denys, A. L., Halkic, N., Demartines, N., & Melloul, E. (2020) · Liver Cancer · doi:10.1159/000505093 · Cited by 49
Esagian, S. M., Kakos, C. D., Giorgakis, E., Burdine, L. J., Barreto, J. C., & Mavros, M. N. (2021) · Cancers · doi:10.3390/cancers13122984 · Cited by 49
Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma
Ladju, R. B., Ulhaq, Z. S., & Soraya, G. V. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i2.176 · Cited by 49
Image-guided thermal ablation of hepatocellular carcinoma
Lencioni, R. A., & Crocetti, L. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.003 · Cited by 49
In‐hospital mortality from liver resection for hepatocellular carcinoma: A simple risk score
Simons, J. P., Ng, S. C., Hill, J. S., Shah, S. A., Zhou, Z., & Tseng, J. F. (2010) · Cancer · doi:10.1002/cncr.24904 · Cited by 49
Modern Diagnosis and Management of Hepatocellular Carcinoma
Marrero, J. A., & Welling, T. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.007 · Cited by 49
Kang, S. H., Kim, D. Y., Jeon, S. M., Ahn, S. H., Park, J. Y., Kim, S. U., Kim, J. K., Lee, K. S., Chon, C. Y., & Han, K. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283535c34 · Cited by 49
Screening for hepatocellular carcinoma
Sherman, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.11.006 · Cited by 49
Prognostic scores for hepatocellular carcinoma: none is the winner
Cammà, C., & Cabibbo, G. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.01994.x · Cited by 49
Rim, C. H., & Yoon, W. S. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s164651 · Cited by 48
Song, M. J., Bae, S. H., Yoo, I. R., Park, C.-H., Jang, J. W., Chun, H. J., Choi, B. G., Lee, H. G., Choi, J. Y., & Yoon, S. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i25.3215 · Cited by 48
Lencioni, R. A. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.10.008 · Cited by 48
Paul, S. B., Shalimar, S., Sreenivas, V., Gamanagatti, S. R., Sharma, H., Dhamija, E., & Acharya, S. K. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13173 · Cited by 48
Zhang, J., Shu, Z.-J., Xie, C.-Y., Li, Q., Jin, X.-H., Gu, W., Jiang, F.-J., & Ling, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088182 · Cited by 48
Luo, J., Yan, Z.-P., Liu, Q., Qu, X.-D., & Wang, J. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.11.029 · Cited by 48
Khor, A. Y. K., Toh, Y. J., Allen, J. C., Ng, D. C., Kao, Y.-H., Zhu, G., Choo, S.-P., Lo, R., Tay, K., Teo, J., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9533-9 · Cited by 48
Lee, B., Ha, S. Y., Song, D. H., Lee, H. W., Cho, S. Y., & Park, C.-K. (2014) · Gut and Liver · doi:10.5009/gnl13392 · Cited by 48
Sieghart, W., Pinter, M., Reisegger, M., Müller, C., Ba‐Ssalamah, A., Lämmer, J., & Peck‐Radosavljevic, M. (2012) · European Radiology · doi:10.1007/s00330-011-2368-z · Cited by 48
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
Mlynarsky, L., Menachem, Y., & Shibolet, O. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.566 · Cited by 48
Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis
Miura, J. T., Johnston, F. M., Tsai, S., Eastwood, D. C., Banerjee, A., Christians, K. K., Turaga, K. K., & Gamblin, T. C. (2015) · HPB · doi:10.1111/hpb.12446 · Cited by 48
Lee, M., Chung, J. W., Lee, K., Won, J. Y., Chun, H. J., Lee, H. C., Kim, J. H., Lee, I. J., Hur, S., Kim, H., et al. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2016.08.017 · Cited by 48
Carcinoma hepatocelular: presente y futuro
Armengol, C., Sarrias, M., & Sala, M. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.08.010 · Cited by 48
Kroh, A., Uschner, D., Lodewick, T. M., Eickhoff, R., Schöning, W., Ulmer, T. F., Neumann, U. P., & Binnebösel, M. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.07.008 · Cited by 48
Validation of a novel model for the early detection of hepatocellular carcinoma
Hemken, P. M., Sokoll, L. J., Yang, X., Dai, J., Elliott, D. J., Gawel, S. H., Lucht, M., Feng, Z., Marrero, J. A., Srivastava, S., et al. (2019) · Clinical Proteomics · doi:10.1186/s12014-018-9222-0 · Cited by 48
Elgebaly, F., Abou-Saif, S., Elkadeem, M. Z., Helmy, A. M., Abd-Elsalam, S. M., Yousef, M., Elkhouly, R. A., Amer, I. F., & El-Demerdash, T. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666190718141647 · Cited by 48
Associated liver partition and portal vein ligation for staged hepatectomy: a review
Chan, K. S., Low, J. K., & Shelat, V. G. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.12.01 · Cited by 48
Zhou, C., Weng, J., Liu, C., Zhou, Q., Chen, W., Hsu, J. L., Sun, J., Atyah, M. M., Xu, Y., Shi, Y., et al. (2020) · PubMed · Cited by 48
Zou, Z.-M., Chang, D., Liu, H., & Xiao, Y. (2021) · Insights into Imaging · doi:10.1186/s13244-021-00977-9 · Cited by 48
Nkontchou, G., Aout, M., Laurent, A., Nahon, P., Ganne‐Carrié, N., Grando, V., Baghad, I., Roulot, D. M., Trinchet, J., Sellier, N., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.026 · Cited by 48
Wang, Z.-X., Jiang, C., Cao, Y., Zhang, G., Chen, W.-B., & Ding, Y.-T. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60353-8 · Cited by 48
Nafee, A. M., Pasha, H. F., Aal, S. M. A. E., & Mostafa, N. A. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.04.024 · Cited by 48
Cucchetti, A., Zanello, M., Cescon, M., Ercolani, G., Gaudio, M. D., Ravaioli, M., Grazi, G. L., & Pinna, A. D. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1463-8 · Cited by 48
Donadon, M., Costa, G., Cimino, M., Procopio, F., Fabbro, D. D., Palmisano, A., & Torzilli, G. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2786-6 · Cited by 48
Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre
Herold, C., Reck, T., Fischler, P., Ott, R., Radespiel‐Tröger, M., Ganslmayer, M., Hohenberger, W., Hahn, E. G., & Schuppan, D. (2002) · Liver International · doi:10.1046/j.0106-9543.2001.01571.x · Cited by 48
Kumar, A., Acharya, S. K., Singh, S. P., Duseja, A. K., Madan, K., Shukla, A., Arora, A., Anand, A. C., Bahl, A., Soin, A. S., et al. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2023.08.005 · Cited by 47
Liu, M., & Wen, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38444 · Cited by 47
ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
Hwang, H. W., Ha, S. Y., Bang, H., & Park, C.-K. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2014.177 · Cited by 47
Colombo, M., Raoul, J., Lencioni, R. A., Galle, P. R., Zucman‐Rossi, J., Bañares, R., Seehofer, D., Neuhaus, P., & Johnson, P. J. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835e33bb · Cited by 47
Kee, K., Wang, J., Lin, C., Wang, C., Cheng, Y., & Lu, S. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2716-8 · Cited by 47
Shen, Y., Zhou, C., Zhu, G., Shi, G., Zhu, X., Huang, C., Zhou, J., Fan, J., Ding, H., Ren, N., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3443-9 · Cited by 47
Ho, S., Hsu, C., Liu, P., Hsia, C., Su, C., Huang, Y., Hou, M., & Huo, T. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.10.541 · Cited by 47
Lu, L.-H., Zhang, Y., Cai, M.-Y., Kan, A., Zhong, X.-P., Mei, J., Ling, Y., Li, S.-H., Shi, M., Wei, W., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.04.006 · Cited by 47
Ghafar, M. T. A., Morad, M. A., El-Zamarany, E. A., Ziada, D. H., Soliman, H. H., Abd-Elsalam, S. M., & Salama, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106375 · Cited by 47
Ardito, F., Famularo, S., Aldrighetti, L. A., Grazi, G. L., DallaValle, R., Maestri, M., Jovine, E., Ruzzenente, A., Baiocchi, G. L., Ercolani, G., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004327 · Cited by 47
Asrani, S. K., Ghabril, M., Kuo, A., Merriman, R. B., Morgan, T. R. M., Parikh, N. D., Ovchinsky, N., Kanwal, F., Volk, M. L., Ho, C. K., et al. (2021) · Hepatology · doi:10.1002/hep.32240 · Cited by 47
Fraquelli, M., Nadarević, T., Colli, A., Manzotti, C., Giljača, V., Miletić, D., Štimac, D., & Casazza, G. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013483.pub2 · Cited by 47
Management of Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis
Lee, H.-S. (2011) · Digestive Diseases · doi:10.1159/000327572 · Cited by 47
Liu, L., Miao, R., Yang, H., Lü, X., Zhao, Y., Mao, Y., Zhong, S., Huang, J., Sang, X., & Zhao, H. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.05.010 · Cited by 47
Actual 10-year survival following hepatectomy for hepatocellular carcinoma
Franssen, B., Jibara, G. A., Tabrizian, P., Schwartz, M., & Roayaie, S. (2013) · HPB · doi:10.1111/hpb.12206 · Cited by 47
Is bacterial ash the flash that ignites NASH?
Farrell, G. C. (2001) · Gut · doi:10.1136/gut.48.2.148 · Cited by 47
Andreana, L., Isgrò, G., Marelli, L., Davies, N., Yu, D., Navalkissoor, S., & Burroughs, A. K. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.004 · Cited by 46
Systemic Therapies in Hepatocellular Carcinoma: Present and Future
Bertino, G., Carlo, I. D., Ardiri, A., Calvagno, G. S., Demma, S., Malaguarnera, G., Bertino, N., Malaguarnera, M., Toro, A., & Malaguarnera, M. (2013) · Future Oncology · doi:10.2217/fon.13.171 · Cited by 46
Kikuchi, L., Paranaguá‐Vezozzo, D. C., Chagas, A. L., de Mello, E. S., Alves, V. A. F., Farias, A. Q., Pietrobon, R. S., & Carrilho, F. J. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31817ff199 · Cited by 46
Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients
Berretta, M., Benedetto, F. D., Maso, L. D., Cacopardo, B. S., Nasti, G., Facchini, G., Bearz, A., Spina, M., Garlassi, E., Re, V. D., et al. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32835c032f · Cited by 46
Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma
El‐Tawdi, A., Matboli, M., Shehata, H. H., Tash, F., El-Khazragy, N. N., Azazy, A. E., & Abdel-Rahman, O. M. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0200-9 · Cited by 47
Hirooka, M., Hiraoka, A., Ochi, H., Kisaka, Y., Joko, K., Michitaka, K., & Hiasa, Y. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18177 · Cited by 46
Rashad, N. M., El‐Shal, A. S., Shalaby, S. M., & Mohamed, S. Y. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3298-8 · Cited by 46
The association of liver function and quality of life of patients with liver cancer
Li, L., Mo, F. K. F., Hui, E. P., Chan, S. L., Koh, J., Tang, N. L. S., Yu, S. C. H., & Yeo, W. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0984-2 · Cited by 46
de Sousa, J. H. B., Calil, I. L., Tustumi, F., Khalil, D. D. C., Felga, G. E. G., Pécora, R. A. A., & de Almeida, M. D. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.01.06 · Cited by 46
Yuan, G., Cheng, X., Li, Q., Zang, M., Huang, W. M., Fan, W., Wu, T., Ruan, J., Dai, W., Yu, W., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s286169 · Cited by 46
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
Labgaa, I., Villanueva, A., Dormond, O., Demartines, N., & Melloul, E. (2021) · Cancers · doi:10.3390/cancers13040659 · Cited by 46
Yeh, H., Chiang, C.-C., & Yen, T. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4104 · Cited by 47
Ishizuka, M., Kubota, K., Kita, J., Shimoda, M., Kato, M., & Sawada, T. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21857 · Cited by 46
Prognosis of patients with spontaneous rupture of hepatocellular carcinoma in cirrhosis
Tarantino, L., Sordelli, I., Calise, F., Ripa, C., Perrotta, M., & Sperlongano, P. (2011) · Updates in Surgery · doi:10.1007/s13304-010-0041-8 · Cited by 46
Murata, S., Tajima, H., Nakazawa, K., Onozawa, S., Kumita, S., & Nomura, K. (2009) · European Radiology · doi:10.1007/s00330-009-1349-y · Cited by 46
Quimioembolización del hepatocarcinoma: partículas cargadas frente a quimioembolización convencional
Puchol, M. D. F., la Parra, C., Esteban, E., Vaño, M., Forment, M., Vera, A., & Cosín, O. (2011) · Radiología · doi:10.1016/j.rx.2010.07.010 · Cited by 46
Kanwal, F., Befeler, A. S., Chari, R. S., Marrero, J. A., Kahn, J. A., Afdhal, N. H., Morgan, T. R. M., Roberts, L. R., Mohanty, S. R., Schwartz, J., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05174.x · Cited by 46
Kim, D. Y., Park, B. J., Kim, Y. H., Han, K., Cho, S. B., Cho, K. R., Uhm, S.-H., Choe, J.-G., Choi, J. Y., Chun, H. J., et al. (2013) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182a78dba · Cited by 46
Lin, C., Hung, C., Chen, W., & Lin, S. (2015) · Liver Cancer · doi:10.1159/000367737 · Cited by 45
Lu, L., Mei, J., Kan, A., Ling, Y., Li, S., Wei, W., Chen, M., Zhang, Y., & Guo, R. (2020) · Cancer Medicine · doi:10.1002/cam4.2951 · Cited by 45
Liver transplantation and conventional surgery for advanced hepatocellular carcinoma
Hwang, S., Moon, D., & Lee, S. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01103.x · Cited by 45
Wang, W.-W., Ang, S. F., Kumar, R., Heah, C., Utama, A., Tania, N. P., Li, H., Tan, S. H., Poo, D., Choo, S. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068904 · Cited by 45
Metadata
- Authors
- Llovet, J., Brú, C., & Bruix, J.
- Affiliations
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 19
- Issue
- 03
- Pages
- 329-338
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2147172608
- Cited by
- 3,805
- References
- 0
- Citations by year
- 2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.